News

FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure

Vapor 2000 and Vapor 3000 devices manufactured by Draegar were improperly cleaned after parts were soldered on, meaning toxic metals could mix with medical gases. Due to the high risk posed to patient health, this recall has earned the FDA’s most serious designation.

warning safety alert recall healthcare issue

FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths

Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately.

Abbott’s Navitor TAVR valve linked to positive real-world outcomes

The intra-annular, self-expanding Navitor valve gained FDA approval in 2023 for the treatment of high-risk heart patients with severe aortic stenosis. This analysis explores its early impact on patient care.

Sunil Rao, MD, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, discusses the heart team approach in the context to determining what is best for the patient in terms of bypass surgery or percutaneous coronary intervention.

Heart teams playing a major role in coronary revascularization decisions

Sunil Rao, MD, discusses the heart team approach in the context of deciding what is best for the patient between bypass surgery and percutaneous coronary intervention.

Heart failure experts share guidance on increasing prevention efforts

Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.

Medicare payment advisors urge Congress to increase radiologist reimbursement

MedPAC, an independent panel of experts that advises lawmakers on payment policy, is endorsing an additional 0.5% update to doc pay, the AMA reports.

Hospital leverages radiology waiting areas to boost cancer screening rates

Boston Medical Center has sought to have patients self-identify for lung cancer screening, administering multilingual surveys while they wait for imaging appointments.

FDA announces recall of Pfizer's fast-tracked sickle cell drug

The drugmaker is voluntarily withdrawing Oxbryta from the market due to a higher-than-acceptable risk of death.

Toothbrush Toothpaste Dental Care Flouride

Public health coalition wins lawsuit against EPA for lack of fluoride oversight

A federal judge in California ruled existing evidence of the negative effects of fluoride in drinking water warrants an investigation and potential action from the Environmental Protection Agency.

doctor wrong patient wrong-site surgery medical error malpractice mistake

Interventional radiologist accused of performing procedure on the wrong patient

Scott W. Peterson, MD, of ProScan imaging was slated to deliver two CT-guided procedures on separate patients at the same time and location.

Patients covered by Medicaid less likely to undergo 20-week ultrasound during pregnancy

Babies born to women with public insurance also face lower odds of being diagnosed with congenital heart defects before birth, new research suggests.

Around the web

Health Exec

FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure